Febrivac 3-Plus Zawiesina do wstrzykiwań
Febrivac 3-Plus Zawiesina do wstrzykiwań
Authorised
- Mink enteritis virus, strain E-MINK F1, Inactivated
- Pseudomonas aeruginosa, serotype 5, strain EP3, Inactivated
- Pseudomonas aeruginosa, serotype 6, strain EP2, Inactivated
- Pseudomonas aeruginosa, serotype 7/8, strain EP1, Inactivated
- Clostridium botulinum, type C, strain Stockholm, toxoid
Product identification
Medicine name:
Febrivac 3-Plus Zawiesina do wstrzykiwań
Active substance:
- Mink enteritis virus, strain E-MINK F1, Inactivated
- Pseudomonas aeruginosa, serotype 5, strain EP3, Inactivated
- Pseudomonas aeruginosa, serotype 6, strain EP2, Inactivated
- Pseudomonas aeruginosa, serotype 7/8, strain EP1, Inactivated
- Clostridium botulinum, type C, strain Stockholm, toxoid
Target species:
-
Mink
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Mink enteritis virus, strain E-MINK F1, Inactivated
-
Pseudomonas aeruginosa, serotype 5, strain EP3, Inactivated
-
Pseudomonas aeruginosa, serotype 6, strain EP2, Inactivated
-
Pseudomonas aeruginosa, serotype 7/8, strain EP1, Inactivated
-
Clostridium botulinum, type C, strain Stockholm, toxoid80.00/percent1.00percent
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Mink
-
All relevant tissuesno withdrawal periodNot applicable.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI20CL01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- IDT Biologika GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- IDT Biologika GmbH
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 1262
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 16/03/2022
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 16/03/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 15/11/2024